TGen News & Press Releases : TGen Clinical Research Services at Scottsdale Healthcare and Mayo Clinic study expands for new cancer drug

City of Hope, TGen announce letter of intent to build cell therapy manufacturing facility in Phoenix

Posted Thursday November 1, 2018

The move would enable the organizations to meet a demand for clinical cell therapies that is expected to grow 42 percent annually over the next decade

Pancreatic cancer survivors celebrate Nov. 4 at TGen’s Step-N-Out run-walk in Scottsdale

Posted Tuesday October 30, 2018

Step-N-Out 5K FUNdraiser supports clinical trials that prolong patient survival; seek end to pancreatic cancer

TGen Distinguished Professor to receive award for advances in treating pancreatic cancer

Posted Monday October 22, 2018

Dr. Daniel D. Von Hoff is honored for ‘tremendous improvements in survival for patients’

Arizona bioscience community honors two of TGen’s top scientists

Posted Wednesday October 3, 2018

Dr. Daniel D. Von Hoff and Dr. Michael E. Berens receive awards recognizing lifetime contributions to biomedical-science leadership and innovation

‘2018 Key to the Cure’ breakfast fashion show set for Oct. 5

Posted Monday September 24, 2018

TGen-Saks event aims to pass the $1 million mark for local cancer research

‘TGen Ambassadors’ recruits 100th member

Posted Wednesday September 19, 2018

Wells Fargo vice president is latest member of TGen Foundation network

TGen participates in today’s launch of NIH-supported Kids First Data Resource Portal

Posted Monday September 10, 2018

TGen and PNOC genomics data from a children’s brain cancer clinical trial to be included in national initiative

TGen-led canine melanoma study identifies genetic basis of disease; potential drug targets

Posted Thursday September 6, 2018

Discoveries among dogs could someday lead to improved genome-based cancer treatments for both dogs and humans

Evening of Trends 2018 fundraising gala benefits TGen

Posted Wednesday September 5, 2018

Trends Magazine charity aligns with TGen focus on women and children

TGen-led study of metastatic melanoma secures $2 million grant

Posted Wednesday August 29, 2018

Goal is to monitor cancer’s response to treatment by sampling tumor DNA in bloodstream

Prev
[1]
2
3
4
5
Next

Search

Media Contact

Newsletter

News Archive

Latest Posts

Useful Links

Contact Us